12 $10 Stocks That Will Triple
According to JPMorgan, the global outlook for securities markets in 2024 suggests a more positive scenario compared to the previous year, with expectations of easing inflation and interest rates.
Essa Pharma Inc. (EPIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 8,748,629 | $57,740,951 | 1.44% | |
| 2. | Soleus Capital Guy Levy | 4,327,622 | $28,562,305 | +1% | 3.16% |
| 3. | Partner Fund Management Christopher Medlock James | 3,262,500 | $21,532,500 | -23% | 1.29% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 1,135,931 | $7,497,145 | +9% | 0.01% |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 677,005 | $4,468,233 | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.30 | 9,223 | 65,675 | 2023-12-14 | Filing | ||
| $5.73 | 23,259 | 784,404 | 2023-11-21 | Filing | ||
| $5.99 | 16,471 | 760,875 | 2023-11-03 | Filing | ||
| $5.35 | 60,000 | 744,404 | 2023-11-02 | Filing | ||
| $2.60 | 3,067 | Officer, Director | 56,542 | 2022-12-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.94 | 694 | 11,940 | 2024-04-05 | Filing | ||
| $8.98 | 694 | Officer | 12,634 | 2024-03-05 | Filing | |
| $10.29 | 72,782 | Officer | 13,328 | 2024-02-06 | Filing | |
| $10.04 | 500 | Officer | 13,328 | 2024-02-05 | Filing | |
| $9.25 | 694 | Officer | 13,328 | 2024-02-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,898,583 | $52,130,648 | 0.79% | |
| 2. | 4,186,578 | $27,631,415 | 0% | |
| 3. | 2,298,662 | $15,171,169 | 0.23% | |
| 4. | 1,089,482 | $7,130,660 | 0% | |
| 5. | 57,466 | $379,276 | 0% |
News See All
These Stocks under $10 Are Poised To Explode
The US equity markets remain on track for a strong finish in 2023 as major indices hover near all-time highs.
Hedge Fund and Insider Trading News: Mike Novogratz, Anthony Scaramucci, Warren Buffett, Bluebell Capital Partners, Coltrane Asset Management, Polen Capital Management, Energy Transfer LP Unit (ET), Occidental Petroleum Corporation (OXY), and More
Coltrane Asset Management reaped profits on a two-year short of tech and growth companies. In late 2020, Mandeep Manku made a big contrarian bet.
Hedge Funds Are Done Buying ESSA Pharma Inc. (EPIX)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
5 Best Biotech Stocks to Buy According to Alan Frazier
In this article, we discuss the 5 best dividend stocks to buy according to Alan Frazier.
Hedge Funds Are Crazy About ESSA Pharma Inc. (EPIX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is EPIX A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think ESSA Pharma Inc. (NASDAQ:EPIX) is a good investment right now.
Hedge Funds Are Souring On ESSA Pharma Inc. (EPIX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On ESSA Pharma Inc. (EPIX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.